about
SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stabilityAccurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesThe histone deacetylase SIRT2 stabilizes Myc oncoproteinsOutcome after reduced chemotherapy for intermediate-risk neuroblastomaExpression of SMARCF1, a truncated form of SWI1, in neuroblastomaNo evidence for involvement of SDHD in neuroblastoma pathogenesiscDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastomaA cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylationIntroduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell deathChemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastomaGenomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma libraryRegulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastomaPediatric cancer research from past successes through collaboration to future transdisciplinary researchThe proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathwayOrganometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generationNoscapine induced apoptosis via downregulation of survivin in human neuroblastoma cells having wild type or null p53Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expressionNBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments.Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genesThe histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastomaIdentification of epigenetically regulated genes that predict patient outcome in neuroblastoma2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma.Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastomaDistinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.Detouring of cisplatin to access mitochondrial genome for overcoming resistanceScreening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells.Murine models for experimental therapy of pediatric solid tumors with poor prognosis.The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo.DNA and histone deacetylases as targets for neuroblastoma treatment.Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival.Neuroblastoma tumour genetics: clinical and biological aspects.
P2860
Q24307488-F750913A-0265-40B3-8B28-028024AC6C17Q24534395-43B8BD2D-774A-4056-8720-7CF47AE8B270Q24622277-50773BB6-B2C0-4767-B190-66717EC93A1DQ24633964-84111C1F-1A7A-42AE-9EA4-ED6ACFED97ABQ24685907-6059FADA-3C4C-4979-8108-C7BE3B78F334Q24791722-6460D230-0A1F-48DA-8B48-C140DB96ACC0Q24796016-C9C09285-81A4-4C88-B86E-6452A799BB65Q24801375-1BA1265D-115B-469A-9C64-953A1EE94E79Q25257689-020E658A-8DEA-47DC-9E74-923224C1BFCDQ26800007-8BDC1BAD-64B6-4426-AAC0-EC6CD42AA2F0Q28214616-8CC40E27-F612-4F81-9071-CF4A1A2D8D97Q28220472-75B5644A-D116-4678-B338-95E31EF394BCQ28249685-C4DB4A58-2ACF-4EA5-9E58-46CDF7F86F93Q28275748-FD46E194-F8A2-4F65-83FB-D75D21DBC5EEQ28477838-B583D595-8939-40E9-8B89-14A81DF3B659Q28477973-DA4D2458-628C-4074-B179-DF6495D9F8A7Q28481583-D997C761-AC64-40BF-ADF3-683160C053B8Q30524404-77CA71F4-A351-4FA5-8C7B-158AAF195861Q30651336-0F266FCD-A79A-4F10-BA34-EF24CF1C7AC6Q30821792-34879D54-D2F3-4FE0-898D-9A5441523053Q31095310-2318F7B2-64CE-476F-B23B-177CE1928149Q33255121-5B4FCB79-D533-4CCA-847F-0E1040552DF1Q33494188-7CBB9DD7-894A-49D9-A234-7A5815FA294AQ33688385-1684DE44-7331-458E-A5D7-55AC47B09F99Q33794045-019BCA75-1EC0-4DB6-A782-F14B55059133Q33818726-6635C28B-18A4-4A39-9663-1E44D71F54F8Q33882364-9C0580AC-C85B-43C4-A1C1-E71770625F26Q33884719-ACBED0D5-D83A-4CA7-8607-0B813F95CF81Q33909753-5203222D-3AA9-4447-B231-662A320BF9F0Q33931217-7E84BE31-3B5D-4D5E-9B9C-FDCD6057E64DQ33972195-2712EFE3-4B3D-4E72-9D23-7331918FE14CQ34191261-42AC9FCD-AC3E-4531-A878-D7CD461E9DA9Q34197920-8EFF1423-30D5-46C3-9DB8-8E0C30920BC9Q34202118-FBABE8D0-C6FF-4D70-AF0B-4A1B53530C95Q34210418-CD92DE13-0FF2-41D1-B639-45E9DF7C2B32Q34299333-98BDB37B-9B03-474C-8511-744F0A3D5AFEQ34320121-07037706-F1DD-448A-943A-EDB3E50A1448Q34323880-0AEA7822-BAB2-4F9F-8B3E-4E55606C75C2Q34438510-8F44D532-B0E0-4543-AC89-5C308B724994Q34453849-C2491519-3E7A-4A9C-854C-CDD665DE0E7B
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular biology of neuroblastoma.
@ast
Molecular biology of neuroblastoma.
@en
type
label
Molecular biology of neuroblastoma.
@ast
Molecular biology of neuroblastoma.
@en
prefLabel
Molecular biology of neuroblastoma.
@ast
Molecular biology of neuroblastoma.
@en
P1476
Molecular biology of neuroblastoma.
@en
P2093
K K Matthay
P304
P356
10.1200/JCO.1999.17.7.2264
P407
P577
1999-07-01T00:00:00Z